Key facts
- Subtle Medical’s last known valuation is $145.0M (Jul 2024).
- It has raised $51.2M; the latest was Later Stage VC in Jul 2025.
- Notable investors include Plug and Play Tech Center, MedTech Innovator, Bessemer Venture Partners, StartX (US), DCVC — 31 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 31 names
- ·Watchlist + deal alerts for Subtle Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Subtle Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Subtle Medical
Operator of a healthcare technology company intended to use deep learning to increase the quality and efficiency of medical imaging. The company's artificial intelligence-powered tool uses proprietary deep learning algorithms that integrate with any scanners to improve image acquisition without any alteration in the existing workflow, enabling imaging centers and hospitals to serve more patients better by scanning more efficiently and enhancing the images.
- Sector
- Healthcare
- HQ
- Menlo Park, CA, United States
- Founded
- 2017
- Employees
- 70
- Website
- subtlemedical.com/
- Ownership
- Privately Held (backing)
Subtle Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Subtle Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Subtle Medical in its N-PORT filings yet. We sweep new filings monthly.